Hemoglobin A2 Percentage (HbA2)
Minor adult hemoglobin tetramer composed of two alpha and two delta globin chains (alpha-2 delta-2).
Standard vs. Optimal Reference Ranges%
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
1.5 - 3.5%
General reference distribution across unselected commercial populations.
2.0 - 3.2%
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Synthesized in small amounts under normal conditions; beta-globin gene mutations divert excess alpha chains to pair with delta chains.
Differential Diagnosis
Elevated Levels (HbA2 High)
- •Beta-Thalassemia Trait (Minor, HbA2 typically 3.6% to 6.5%)
- •Hyperthyroidism
Low Levels (HbA2 Low)
- •Iron deficiency anemia (falsely lowers HbA2, masking mild thalassemia)
- •Alpha-thalassemia trait
- •Delta-thalassemia
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for HbA2
- Targeted organ system imaging or functional dynamic testing related to beta-thalassemia trait screening
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Hemoglobin A2 Percentage - The New England Journal of Medicine (2021). PMID: 34090124
- [2]HbA2 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Hemoglobin A2 Percentage (HbA2) into overall healthspan optimization.